10
Participants
Start Date
April 30, 2024
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
budesonide / glycopyrronium / formoterol
"Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension.~The COnCORD study is an observational study that will be conducted in a real-life setting in Romania and is not designed to evaluate medicinal products given according to a specific randomised schedule. Treatment with BGF MDI treatment prescribed as per current practice, according to the SmPC and local market reimbursement criteria"
Research Site, Baia Mare
Research Site, Bucharest
Research Site, Cluj-Napoca
Research Site, Constanța
Research Site, Craiova
Research Site, Deva
Research Site, Dorohoi
Research Site, Hunedoara
Research Site, Iași
Research Site, Luduş
Research Site, Medgidia
Research Site, Oradea
Research Site, Sighișoara
Research Site, Suceava
Research Site, Târgu Mureş
Research Site, Timișoara
Lead Sponsor
AstraZeneca
INDUSTRY